metforminFinding
Metformin decreases all-cause mortality
lowersModerate evidenceFindingreplicated ×1
01 · The sentence it was drawn from
“Before weighting, the 30-day and five-year mortalities after surgery were lower in the metformin group than in the non-metformin group (0.3% vs. 1.0%; P < 0.001 for 30-day mortality and 13.6% vs. 19.7%; P < 0.001 for five-year mortality).”
metformin
All- cause mortality
lowers
- Who
- adults with type 2 diabetes undergoing noncardiac surgery, metformin users vs non-users; secondary endpoint, unadjusted (before IPTW weighting), five-year follow-up horizon
- Dose studied
- not reported
Moderate evidencePMID 41208045 · 2026
02 · The study
- Study
- cohort
- Duration
- not reported
Evidence, by strength
- strong
- moderatethis finding
- limited
- very limited
- insufficient
03 · The paper
Korean journal of anesthesiology04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M3RHTEZPNAA899PJWEBA9JV4